https://orcid.org/0000-0001-5058-1112
References
- Weinstein JN , CollissonEA , MillsGBet al. The cancer genome atlas pan-cancer analysis project. Nat. Genet.45(10), 1113–1120 (2013).
- Porter S , ClarkIM , KevorkianL , EdwardsDR. The ADAMTS metalloproteinases. Biochem. J.386(Pt 1), 15–27 (2005).
- Apte SS . A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin Type 1 motif (ADAMTS) superfamily: functions and mechanisms. J. Biol. Chem.284(46), 31493–31497 (2009).
- Sun Y , HuangJ , YangZ. The roles of ADAMTS in angiogenesis and cancer. Tumor Biol.36(6), 4039–4051 (2015).
- Clark ME , KelnerGS , TurbevilleLA , BoyerA , ArdenKC , MakiRA. ADAMTS9, a novel member of the ADAM-TS/ metallospondin gene family. Genomics67(3), 343–350 (2000).
- Goharitaban S , AmiriI , SoleimaniAsl Set al. Abnormal expressions of ADAMTS-1, ADAMTS-9 and progesterone receptors are associated with lower oocyte maturation in women with polycystic ovary syndrome. Arch. Gynecol. Obstet.299(1), 277–286 (2019).
- Coughlan TC , CrawfordA , GoldringMB , HattonPV , BarkerMD. Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. J. Tissue Eng. Regen. Med.4(8), 611–618 (2010).
- Li S , LiT , LiXet al. MicroRNA-32 regulates development and progression of hepatocellular carcinoma by targeting ADAMTS9 and affects its prognosis. Med. Sci. Monit. Basic Res.24(24),177–187 (2018).
- Du W , WangS , ZhouQet al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene32(28), 3319–3328 (2013).
- Lo PH , LungHL , CheungAKet al. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res.70(13), 5567–5576 (2010).
- Blelloch R , KimbleJ. Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegans. Nature399(6736), 586–590 (1999).
- Benz BA , NandadasaS , TakeuchiMet al. Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion. Dev. Biol.416(1), 111–122 (2016).
- Wang LW , NandadasaS , AnnisDS , DubailJ. A disintegrin-like and metalloproteinase domain with thrombospondin Type 1 motif 9 (ADAMTS9) regulates fibronectin fibrillogenesis and turnover. J. Biol. Chem.294(25), 9924–9936 (2019).
- Viloria CG , ObayaAJ , Moncada-PazosAet al. Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res.69(11), 4926–4934 (2009).
- Lo PH , LeungAC , KwokCYet al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene26(1), 148–157 (2007).
- Li Z , ZhangW , ShaoYet al. High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers. Med. Oncol.27(3), 998–1004 (2010).
- Shao B , FengY , ZhangHet al. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer. J. Cell Mol. Med.22(2), 1257–1271 (2018).
- Peng L , YangZ , TanC , RenG , ChenJ. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma. Mol. Med. Rep.7(3), 1055–1061 (2013).
- Koo BH , CoeDM , DixonLJet al. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am. J. Pathol.176(3), 1494–1504 (2010).
- Hong W , GuY , GuanR , XieD , ZhouH , YuM. Pan-cancer analysis of the CASP gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets. Genomics112(6), 4304–4315 (2020).